PNC Financial Services Group
AUPH icon

PNC Financial Services Group’s Aurinia Pharmaceuticals AUPH Stock Holding History

PNC Financial Services Group’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.8K Buy
1,050
+112
+12% +$1.79K ﹤0.01% 3832
2026
Q1 		$13.9K Buy
938
+237
+34% +$3.46K ﹤0.01% 3836
2025
Q4 		$11.2K Buy
701
+535
+322% +$7.58K ﹤0.01% 3911
2025
Q3 		$1.83K Sell
166
-260
-61% -$2.84K ﹤0.01% 4524
2025
Q2 		$3.61K Sell
426
-172
-29% -$1.38K ﹤0.01% 4236
2025
Q1 		$4.81K Buy
598
+436
+269% +$3.53K ﹤0.01% 4080
2024
Q4 		$1.46K Hold
162
– – ﹤0.01% 4356
2024
Q3 		$1.19K Hold
162
– – ﹤0.01% 4408
2024
Q2 		$925 Buy
+162
New +$853 ﹤0.01% 4443
2024
Q1 		– Sell
-8
Closed -$72 – 4699
2023
Q4 		$72 Buy
+8
New +$66 ﹤0.01% 4535
2022
Q4 		– Sell
-2,370
Closed -$18K – 4762
2022
Q3 		$18K Buy
2,370
+26
+1% +$225 ﹤0.01% 3484
2022
Q2 		$23K Buy
2,344
+124
+6% +$1.39K ﹤0.01% 3423
2022
Q1 		$27K Sell
2,220
-31,050
-93% -$480K ﹤0.01% 3431
2021
Q4 		$761K Buy
33,270
+30,909
+1,309% +$732K ﹤0.01% 1440
2021
Q3 		$52K Sell
2,361
-49,971
-95% -$793K ﹤0.01% 3044
2021
Q2 		$678K Sell
52,332
-3,881
-7% -$49.4K ﹤0.01% 1425
2021
Q1 		$730K Buy
56,213
+52,213
+1,305% +$758K ﹤0.01% 1331
2020
Q4 		$55K Sell
4,000
-25
-0.6% -$364 ﹤0.01% 2837
2020
Q3 		$59K Buy
4,025
+4,000
+16,000% +$57.9K ﹤0.01% 2643
2020
Q2 		$0 Hold
25
– – ﹤0.01% 3906
2020
Q1 		$0 Hold
25
– – ﹤0.01% 3888
2019
Q4 		$1K Buy
+25
New +$230 ﹤0.01% 3866
2018
Q4 		– Sell
-3,000
Closed -$20K – 4029
2018
Q3 		$20K Hold
3,000
– – ﹤0.01% 3441
2018
Q2 		$16K Hold
3,000
– – ﹤0.01% 3515
2018
Q1 		$16K Buy
+3,000
New +$16.1K ﹤0.01% 3520
2017
Q1 		– Sell
-800
Closed -$2K – 4109
2016
Q4 		$2K Buy
+800
New +$2.57K ﹤0.01% 3818

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PNC Financial Services Group's AUPH Position: Q2 2026 in Review

PNC Financial Services Group increased its Aurinia Pharmaceuticals (AUPH) stake by 12% in Q2 2026, buying an estimated $1.79K and bringing the position to 1,050 shares worth $17.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3832.

PNC Financial Services Group first reported a position in AUPH in Q4 2016 and has held it in 26 quarters since. The position peaked at $761K in Q4 2021. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • PNC Financial Services Group held 1,050 shares of Aurinia Pharmaceuticals worth $17.8K as of Q2 2026.
  • PNC Financial Services Group bought 112 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $1.79K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3832 holding.
  • PNC Financial Services Group first reported a position in Aurinia Pharmaceuticals in Q4 2016 and has held it in 26 quarters since.
  • PNC Financial Services Group's Aurinia Pharmaceuticals position peaked at $761K in Q4 2021.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.